Fluorinated isoindolinone-amino acid hybrids possessing antiproliferative and antitumor activity in vitro and in vivo.
F fluorinated isoindolinone-amino acid conjugates are identified as promising anticancer leads targeting CDK2-associated cell-cycle signaling against triple-negative breast cancer.